EP0578767A4 - Alkaline protease 3733, its production and use in cleaning contact lens. - Google Patents

Alkaline protease 3733, its production and use in cleaning contact lens.

Info

Publication number
EP0578767A4
EP0578767A4 EP19920910656 EP92910656A EP0578767A4 EP 0578767 A4 EP0578767 A4 EP 0578767A4 EP 19920910656 EP19920910656 EP 19920910656 EP 92910656 A EP92910656 A EP 92910656A EP 0578767 A4 EP0578767 A4 EP 0578767A4
Authority
EP
European Patent Office
Prior art keywords
protease
enzyme
activity
alkaline
cleansing preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920910656
Other languages
German (de)
French (fr)
Other versions
EP0578767A1 (en
Inventor
Joy T Barnitz
Michael J Fiske
Susan M Middlebrook
Darrell Bernie Steele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco US Inc
Original Assignee
Genencor International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor International Inc filed Critical Genencor International Inc
Publication of EP0578767A1 publication Critical patent/EP0578767A1/en
Publication of EP0578767A4 publication Critical patent/EP0578767A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0078Compositions for cleaning contact lenses, spectacles or lenses
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38618Protease or amylase in liquid compositions only
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus

Definitions

  • This invention relates to a novel alkaline protease or elastase enzyme "protease 3733" having an activity capable of dissolving denatured lysozyme, a production method thereof, and the process of using protease 3733 in cleaning contact lenses.
  • the presently used method for removing deposited protein involves soaking the lenses in a protease (such as subtilisin Carlsberg) solution at room temperature, soaking in a protease in a thermal disinfecting unit, or soaking in a chemical disinfectant.
  • a protease such as subtilisin Carlsberg
  • the denaturation of protein on the lens surface presents a problem in cleaning the lens, especially when thermal disinfecting is used.
  • the predominant protein deposited on the lens is lysozyme secreted by the user's tear ducts.
  • the removal of lysozyme from lens is difficult using conventional proteases, such as subtilisin, especially when the lysozyme has been denatured by thermal disinfecting.
  • Tne present invention is a novel alkaline protease which overcomes the relative inefficiency of conventional proteases in removing denatured lysozyme from contact lenses.
  • protease 3733 a novel alkaline protease, also called an elastase, named "protease 3733" is described.
  • the enzyme was produced by fermentation of a newly isolated Bacillus sp. strain IAM 011105.
  • the structural and biochemical properties of protease 3733 are described and compared to other proteases.
  • This enzyme has an unusual degree of activity in hydrolyzing denatured lysosyme. Denatured lysozyme is the prime contaminant affecting contact lenses.
  • the new enzyme is also highly active on the insoluble fibrous protein ela ⁇ tin.
  • protease 3733 to clean contact lenses is described.
  • Fig. 1a shows the effect of pH on activity of protease 3733 in hydrolyzing azocasein.
  • Fig. 1b shows the effect of pH on stability of protease 3733 at 4° C and at 23° C.
  • Fig. 1c shows the effect of temperature on activity of protease 3733 in hydrolyzing azocasein.
  • Fig. 1d shows the effect of 40° C at pH 8 and pH 10 on stability of protease 3733.
  • Fig. 1e shows the effect of 50° C at pH 8 and pH 10 on stability of protease 3733.
  • Fig. 2a shows the effect of chelating agent EDTA and the serine protease inhibitor PM ⁇ F on activity of protease 3733.
  • Fig. 2b shows the effect of EDTA at pH 10 and 40° C on stability of protease 3733
  • Fig. 2c shows the effect of divalent cations at pH 10 and 50° C on stability of protease 3733.
  • Fig. 3 shows the comparative hydrolysis of denatured lysozyme by protease 3733, subtilisin Carlsberg, subtilisin aprE, and subtilisin BPN'.
  • Fig. 4 shows the comparative hydrolysis of denatured human milk lysozyme by protease 3733 and subtilisin Carlsberg with and without BME.
  • Fig. 5 shows the comparative hydrolysis of denatured human milk lysozyme by protease 3733 and subtilisin Carlsberg with and without BME.
  • Bacillus sp. IAM 011105 was isolated from the aeration basin of an activated sludge facility used to treat textile finishing waste. The waste temperature was 20° C and the pH was 10.4. A small volume (0.1 ml) of waste slurry was added to 5.0 ml of 4g/liter nutrient broth (Difco, Detroit, Mich.) buffered at pH 10.5 with 0.05 M 3-cyclohexylamino-1-propanesulfonic acid (CAPS; Sigma Chemical, St. Louis, MO). This culture was incubated at 30° C for 10 days. The broth was then streaked on solid medium of above composition plus 1.5% Noble agar and 10% skim milk then incubated at 30° C for 3 days. Strain IAM 011105 was isolated as a single colony exhibiting hydrolysis of skim milk casein.
  • Strain IAM 011105 is a gram positive bacterium. At pH 7.5 it grows as a straight rod 0.5 - 1.0um x 5.0 - 8.0 urn. At pH 9.0 it grows as long thin rods approximately 0.5 um x 5.0 to greater than 15 um. Sporulation was not observed in any cultures. Colonies on Tryptic Soy Agar pH 7.5 are cream colored, opaque, circular, and convex with an entire margin. Colonies on Tryptic Soy Agar pH 9.0 are cream colored, opaque, irregular, and flat with an erose margin.
  • Bacillus sp. IAM 011105 has been deposited under No. 55142 with the American Type Culture Collection, Rockville, Maryland. Tnese data indicate that strain IAM 011105 is a previously undescribed bacterial species of the genus Bacillus.
  • This invention relates to the culturing of a bacterium of the order Eubacteriales, family Bacillaceae, genus Bacillus, and to collecting and purifying protease 3733 from the culture medium.
  • a fernbach flask containing 500 ml of 30 g/1 tryptic soy broth buffered to pH 9.0 with 0.05M CAPS was inoculated with 1.0 ml frozen stock of Bacillus sp. IAM 011105, The culture was shaken overnight at 200 rpm at 30° C. This was used to inoculate a 14 1 Chemap fermenter containing 10 1 of the same media. Cells were grown for 48 hours at 30° C with an agitation of 1300 rpm with an airflow of 8 liters per minute. Cells were spearated from the culture broth via centrifugation in a Sorvall RC-5B centrifuge and the cells discarded.
  • Enzyme purification The clarified culture medium was concentrated with a YM-10 ultrafiltration membrane with a 10,000 dalton cutoff, obtained from Amicon, a division of W.R. Grace & Co., Beverly, MA. 30 ml of concentrate was passed over a 100 ml SEPHADEX G-25 column equilibrated with 0.01M sodium acetate and 1.OmM CaCl, pH 5.5. SEPHADEX is a trademarkfor gel separation media owned by Pharmacia, Piscataway, NJ . The desalted material was applied to a Pharmacia FPLC Mono ⁇ HR 10/10 column equilibrated with the same buffer. Protease 3733 was eluded from the column using a 90 ml linear 0 - 0.2M NaCl gradient in the above buffer.
  • Tne resulting preparation of protease 3733 was shown to be homogeneous via SDS-PAGE, IEF, and N-terminal sequencing. Purified protease is stored at 4° C as a 1.0 mg/ l solution in column elution buffer with 50% propylene glycol.
  • Protein concentration was determined using the Bio-Rad protein assay kit (Bio-Rad, Rockville Centre, NY).
  • Figs. 1a - e shows several biochemical properties of protease 3733. Unless indicated, all data were determined under the following conditions. All studies were done with protease 3733 prepared as above and stored as indicated. Enzymatic acitvity was determined using azocasein (Sigma Chemical Co., St. Louis, MO) as the substrate. 0.5% azocasein was prepared in 0.05M tris (hydroxymethyl) aminomethane (Tris) buffer (Sigma Chemical Co., St. Louis, MO) plus 1.OmM CaCl adjusted to pH 8.0 with HCl. 100ul of an appropriate enzyme dilution was added to 900ul of 0.5% azocasein and incubated at 30° C for 10 minutes.
  • Tris tris (hydroxymethyl) aminomethane
  • the reaction was stopped by the addition of 300ul of 10% trichloroacetic acid.
  • the reaction mixture was centrifuged at 12,000 rpm for 2 minutes in an Eppendorf microfuge. 800ul of supernatant fluid was withdrawn into a fresh tube containing 300ul of 0.5 N NaOH.
  • the mixture was vortexed and the absorbanc read at 420nm.
  • One unit of activity is the amount of enzyme required to give an absorbance change of 1.0 in 1 minute.
  • the Activity axis represents the % relativ activity calculated by comparison of each point to the highest value, which is given a relative activity of 100.
  • Fig. 1a shows the effect on the activity of protease 3733 on azocasein found by varying the pH values from 4 - 12.
  • the data in Fig. 1a indicate that protease 3733 activity against azocasein had a pH optimum of at least pH 11.
  • Fig. 1b shows the effect of pH on stability of protease 3733.
  • the enzyme at a concentration of 1mg/ml, was incubated at pH values from 4 - 12 at 4° C, dashed line; or at 23° C, solid line, for 20 hrs. and the activity was determined.
  • the data in Fig. 1b. indicate that protease 3733 was stable for 20 hrs. at pH 5 - 9 at 4° C and stable for 20 hrs. at pH 7 - 9 at 23° C.
  • Fig. 1c shows the effect of temperature on activity of protease 3733. Enzymatic activity was determined at 10° - 70° C. The data in Fig. 1c indicate a temperature optimum of 50° C.
  • Fig. 1d shows the effect of 40° C on stability of protease 3733.
  • the enzyme at a concentration of 1mg/ml was incubated for up to 120 min. at 40° C at a pH of 8, dashed line; or pH of 10, solid line; and the enzymatic activity determined.
  • the data in Fig. 1d show that protease 3733 is stable at 40° C at pH 8 or pH 10.
  • Fig. 1e shows the effect of 50° C on stability of protease 3733.
  • the enzyme was incubated for up to 120 min. at 50° C at a pH of 8, solid line; or pH of 10, dashed line; and the enzymatic activity determined.
  • the data in Fig. 1d show that protease 3733 loses 50% of its activity after 15 min. at 50° C at both pH 8 and pH 10.
  • Figs. 2a - c show the effects of various additives on the activity of protease 3733. ' Unless indicated otherwise, the conditions were the same as in Figs. 1a - e.
  • Fig. 2a shows the effect of (1) phenylmethylsulfonyl fluoride (PMSF) and (2) ethylenedia inetetraacetic acid (EDTA) on protease 3733 activity.
  • PMSF phenylmethylsulfonyl fluoride
  • EDTA ethylenedia inetetraacetic acid
  • Fig. 2b shows the effect of EDTA on the stability of protease 3733.
  • the enzyme was incubated for up to 120 min. at pH 10 and 40° C in the presence and absence of EDTA at a concentration of 2.OmM and the activity was determined.
  • Crosses indicated presence of EDTA points and triangles indicated control points lacking EDTA.
  • the data in Fig. 2b indicate that EDTA drastically reduced the stability of protease 3733.
  • Fig. 2c shows the effect of divalent cations on stability of protease 3733. Chloride salts of a variety of cations were added to separate aliquots of enzyme solution which were held at pH 10 and 50° C for up to 120 min. At intervals indicated, samples were taken from each aliquot and the enzyme activity determined. All experimental salts were at a final concentration of 5.OmM. The experimental points on Fig. 2c are as follows: triangle, control; cross, Ba ; open square, Ca ; closed square,
  • Figs. 2a - c are typical for Bacillus alkaline proteases.
  • protease 3733 The specific activity of protease 3733 was examined on several substrates including azocasein, N-succinyl-ala-ala-pro- phe p-nitroanilide (AAPF-pna), N-succinyl-ala-ala-ala p-nitroanilide (AAA-pna) , and elastin congo red, all obtained from Sigma Chemical Co., St. Louis, MO. Specific activities were compared to those obtained with subtilisin Carlsberg and subtilisin aprE.
  • Enzyme assays with AAPF-pna and AAA-pna as substrates were performed as follows. 1 0mM AAPF-pna or AAA-pna was prepared in dimethylsulfoxide. Reaction mixtures contained 980ul of 50mM Tris-HCl (pH 8.0) + 1.0mM CaCl, 1 Oul of either AAPF-pna or AAA-pna, and 1Oul of an appropriate enzyme dilution. The increase in absorbance at 410nm, due to the release of p-nitroaniline, was followed continuously at 25°C. One unit of activity is the amount of enzyme required to give an absorbance change of 1.0 in 1 minute.
  • Enzyme assays with elastin congo red were performed as follows. 1 O g of elastin congo red (Sigma Chemical Co., St. Louis, MO) was weighed into 13x100mm test tubes. 900ul of 50mM Tris-HCl (pH 8.0) + 1.0mM CaCl was added followed by the addition of 100ul of an appropriate enzyme dilution. tubes were capped and incubated for 30 minutes at 37° C with shaking. the reaction was stopped by the addition of 1.0 ml of 0.7M KPO. (pH 5.5), the tubes centrifuged at 3000 rpm for 10 minutes, and the absorbance of the supernatant fluid read at 495nm. One unit of activity is the amount of enzyme required to give an absorbance change of 1.0 in 1 minute.
  • Table 2 gives the specific activities of protease 3733 on the indicated substrates in comparison to those of subtilisin Carlsberg and subtilisin aprE. Specific activities are expressed as Units/mg of enzyme.
  • the data in Table 2 indicate that the specific activity of protease 3733 on several of the substrates examined is significantly different from that of subtilisin Carlsberg and from that of subtilisin aprE.
  • the specific activity of protease 3733 is similar to that of the subtilisins on azocasein. However, the specific activity of protease 3733 is higher than that of subtilisin aprE, and much lower than that of subtilisin Carlsberg on AAPF-pna.
  • protease 3733 is much higher than that of either subtilisin on AAA-pna.
  • the specific activity of protease 3733 is much higher than that of either subtilisin on Elastin congo red. This indicates that protease 3733 is a different and distinct enzyme from either subtilisin Carlsberg or subtilisin aprE.
  • composition of Protease 3733 The amino acid compositions of protease 3733, subtilisin Carlsberg, and elastase Ya-B are compared in Table 3.
  • Elastase Ya-B is an alkaline elastase isolated from Bacillus sp. Ya-B as described in Biochim Biophys Acta, 1986, 833, pages 439-447. The enzymes were hydrolyzed and the resultant component amino acids analyzed. Table 3 shows the number of amino acid residues which resulted from the hydrolysis of each enzyme.
  • the amino acid compositions of protease 3744, subtilisin Carlsberg, and elastase Ya-B differ significantly from each other and indicate that these are different enzymes.
  • protease 3733 subtilisin Carlsberg, and elastase Ya-B were determined and are shown in the section "Sequence Listing" as SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3, respectively.
  • Table 4 shows the N-terminal sequence of these enzymes. Stars in Table 4 indicate amino acids homologous to protease 3733.
  • Protease 3733 exhibits 50% homology with subtilisin Carlsberg and 34% homology with elastase Ya-B in the N-terminal sequence of these enzymes. This indicates that the three enzymes are distinctly different proteins.
  • Protease 3733 and Other Proteases Table 5 compares several biochemical properties of pronase 3733 with those of subtilisin Carlsberg and elastase Ya-B. Unless indicated, these properties were determined as in Fig 1a - e. Data for elastase Ya-B were obtained from the above publication.
  • protease 3733 had a much lower pi than elastase Ya-B and subtilisin Carlsberg and protease 3733 had a lower pi than serine proteases in general.
  • Protease 3733 exhibited some degree of cross-reactivity with subtilisin Carlsberg antibodies whereas elastase Ya-B had none.
  • the ratio of ela ⁇ tin/casein degrading activity was highest for elastase Ya-B, with the ratio for protease 3733 approximately nine times that of the ratio for subtilisin Carlsberg.
  • B. subtilis elastase is an elastase isolated from B. subtilis as described in Canadian Journal of Microbiology, 1988, 34, p. 855-859.
  • Lysozyme hydrolysis assays were performed as follows. A 1.0 mg/ l solution of chicken eggwhite lysozyme (Sigma Chemical Co., St. Louis, MO) was prepared in 5OmM sodium borate (pH 8.0) and 1.0 ml of this solution was aliquoted into 13x100mm test tubes. The tubes were capped and placed in a boiling water bath for 5 minutes resulting in denaturation of the lysozyme. After allowing the tubes to cool, 100 ul of an appropriate enzyme dilution was added and the reaction mixture was incubated at 37° C for 30 minutes.
  • reaction was stopped by the addition of 300 ul of 10% trichloroacetic acid followed by centrifugation at 3000 rpm for 10 minutes.
  • absorbance of soluble amino acids in the supernatant fluid was read at 380nm.
  • Assays using human milk lysozyme (Sigma Chemical Co., St. Louis, MO) were performed using this same protocol. Any changes in incubation temperature or incubation time are indicated where appropriate.
  • Fig. 3 illustrates the enzymatic activity of protease 3733, subtilisin Carlsberg, subtilisin aprE, and subtilisin BPN'on denatured eggwhite lysozyme. Activity was determined by incubating 25ug of purified enzyme with denatured eggwhite lysozyme under the conditions described above. The data show protease 3733 to be 5 - 6 fold more active at- hydrolyzing denatured eggwhite lysozyme than the other proteolytic enzymes.
  • Fig. 4 shows the effect of beta-mercaptoethanol (BME) on enzymatic activity of protease 3733 and subtilisin Carlsberg on denatured eggwhite lysozyme.
  • BME beta-mercaptoethanol
  • Fig. 5 shows the activity of protease 3733 and subtilisin Carlsberg on denatured human milk lysozyme with and without the addition of 0.4% BME.
  • protease 3733 exhibited a 4 - 5 fold higher activity on human milk lysozyme than did subtilisin Carlsberg.
  • the addition of BME resulted in a two-fold enhancement of enzymatic activity for both enzymes.
  • protease 3733 without addition of BME was 1.5 - 2 fold more active on denatured human milk lysozyme than was subtilisin Carlsberg enhanced with BME.
  • Protein-contaminated contact lenses may be cleaned by incubation in a cleansing preparation containing protease 3733.
  • a suitable preparation is a sterile aqueous solution of 0.05 M sodium borate buffer pH 8.0 with protease 3733 at 1 mg/ml. Contaminated contact lens are immersed in the preparation and held at room temperature for 30 min. The lenses are rinsed well with sterile physiological saline before use. Protein contamination is effectively removed from contact lenses using this preparation and method.
  • 0.4% BME may be included in preparation.
  • Suitable cleansing preparations also may be formulated in nonaqueous solvents, such as hexane, cyclohexane, ethanol, methanol, and dimethylsulfoxide. Such solutions may be buffered to insure a high level of enzymatic activity.
  • the method of use is as for agueous solutions.
  • ORGANISM Bacillus sp.
  • ORGANISM Bacillus sp.
  • NAME/KEY N-terminal sequence of alkaline protease, elastase Ya-B
  • IAM 011105 said culture being capable of producing the alkali protease enzyme "protease 3733" in a recoverable quantity upon fermentation in an aqueous nutrient medium containing assimilab sources of carbon, nitrogen, and inorganic substances.

Abstract

The fermentation and isolation of a novel alkaline protease, protease 3733 is described. This enzyme has the properties of an elastase and a serine protease. This enzyme is produced by a newly discovered alkalophilic Bacillus sp. IAM 011105 bacterium. Protease 3733 is characterized by high activity in hydrolyzing denatured lysozyme and the use of this enzyme in cleaning contact lenses is described. The biochemical properties of the new enzyme are described and the activity of the enzyme on a variety of substrates under a variety of conditions is described and compared to other alkaline proteases.

Description

ALKALINE PROTEASE 3733, ITS PRODUCTION AND USE IN CLEANING CONTACT LENS
BACKGROUND OF THE INVENTION FIELD OF THE INVENTION
This invention relates to a novel alkaline protease or elastase enzyme "protease 3733" having an activity capable of dissolving denatured lysozyme, a production method thereof, and the process of using protease 3733 in cleaning contact lenses.
DESCRIPTION OF RELATED ART
Users of soft contact lenses must clean and disinfect their lenses for reasons of health and comfort. In addition to cleaning lenses with detergent, it is also necessary to remove protein deposit from the surface of the lenses. The presently used method for removing deposited protein involves soaking the lenses in a protease (such as subtilisin Carlsberg) solution at room temperature, soaking in a protease in a thermal disinfecting unit, or soaking in a chemical disinfectant.
The denaturation of protein on the lens surface presents a problem in cleaning the lens, especially when thermal disinfecting is used. The predominant protein deposited on the lens is lysozyme secreted by the user's tear ducts. The removal of lysozyme from lens is difficult using conventional proteases, such as subtilisin, especially when the lysozyme has been denatured by thermal disinfecting.
Tne present invention is a novel alkaline protease which overcomes the relative inefficiency of conventional proteases in removing denatured lysozyme from contact lenses.
SUMMARY OF THE INVENTION The fermentation and isolation of a novel alkaline protease, also called an elastase, named "protease 3733" is described. The enzyme was produced by fermentation of a newly isolated Bacillus sp. strain IAM 011105. The structural and biochemical properties of protease 3733 are described and compared to other proteases. This enzyme has an unusual degree of activity in hydrolyzing denatured lysosyme. Denatured lysozyme is the prime contaminant affecting contact lenses. The new enzyme is also highly active on the insoluble fibrous protein elaεtin. The use of protease 3733 to clean contact lenses is described.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1a shows the effect of pH on activity of protease 3733 in hydrolyzing azocasein.
Fig. 1b shows the effect of pH on stability of protease 3733 at 4° C and at 23° C.
Fig. 1c shows the effect of temperature on activity of protease 3733 in hydrolyzing azocasein.
Fig. 1d shows the effect of 40° C at pH 8 and pH 10 on stability of protease 3733.
Fig. 1e shows the effect of 50° C at pH 8 and pH 10 on stability of protease 3733. Fig. 2a shows the effect of chelating agent EDTA and the serine protease inhibitor PMΞF on activity of protease 3733. Fig. 2b shows the effect of EDTA at pH 10 and 40° C on stability of protease 3733
Fig. 2c shows the effect of divalent cations at pH 10 and 50° C on stability of protease 3733.
Fig. 3 shows the comparative hydrolysis of denatured lysozyme by protease 3733, subtilisin Carlsberg, subtilisin aprE, and subtilisin BPN'.
Fig. 4 shows the comparative hydrolysis of denatured human milk lysozyme by protease 3733 and subtilisin Carlsberg with and without BME.
Fig. 5 shows the comparative hydrolysis of denatured human milk lysozyme by protease 3733 and subtilisin Carlsberg with and without BME.
DESCRIPTION OF THE PREFERRED EMBODIMENT Strain Isolation. Bacillus sp. IAM 011105 was isolated from the aeration basin of an activated sludge facility used to treat textile finishing waste. The waste temperature was 20° C and the pH was 10.4. A small volume (0.1 ml) of waste slurry was added to 5.0 ml of 4g/liter nutrient broth (Difco, Detroit, Mich.) buffered at pH 10.5 with 0.05 M 3-cyclohexylamino-1-propanesulfonic acid (CAPS; Sigma Chemical, St. Louis, MO). This culture was incubated at 30° C for 10 days. The broth was then streaked on solid medium of above composition plus 1.5% Noble agar and 10% skim milk then incubated at 30° C for 3 days. Strain IAM 011105 was isolated as a single colony exhibiting hydrolysis of skim milk casein.
Strain IAM 011105 is a gram positive bacterium. At pH 7.5 it grows as a straight rod 0.5 - 1.0um x 5.0 - 8.0 urn. At pH 9.0 it grows as long thin rods approximately 0.5 um x 5.0 to greater than 15 um. Sporulation was not observed in any cultures. Colonies on Tryptic Soy Agar pH 7.5 are cream colored, opaque, circular, and convex with an entire margin. Colonies on Tryptic Soy Agar pH 9.0 are cream colored, opaque, irregular, and flat with an erose margin.
Biochemical characteristics of Bacillus sp. IAM 011105 were determined using the Minitek Disc System (Becton Dickinson, Cockeysville, MD). The results are shown in Table 1.
Bacillus sp. IAM 011105 has been deposited under No. 55142 with the American Type Culture Collection, Rockville, Maryland. Tnese data indicate that strain IAM 011105 is a previously undescribed bacterial species of the genus Bacillus.
Enzyme Production and Purification. This invention relates to the culturing of a bacterium of the order Eubacteriales, family Bacillaceae, genus Bacillus, and to collecting and purifying protease 3733 from the culture medium.
A fernbach flask containing 500 ml of 30 g/1 tryptic soy broth buffered to pH 9.0 with 0.05M CAPS was inoculated with 1.0 ml frozen stock of Bacillus sp. IAM 011105, The culture was shaken overnight at 200 rpm at 30° C. This was used to inoculate a 14 1 Chemap fermenter containing 10 1 of the same media. Cells were grown for 48 hours at 30° C with an agitation of 1300 rpm with an airflow of 8 liters per minute. Cells were spearated from the culture broth via centrifugation in a Sorvall RC-5B centrifuge and the cells discarded.
Enzyme purification. The clarified culture medium was concentrated with a YM-10 ultrafiltration membrane with a 10,000 dalton cutoff, obtained from Amicon, a division of W.R. Grace & Co., Beverly, MA. 30 ml of concentrate was passed over a 100 ml SEPHADEX G-25 column equilibrated with 0.01M sodium acetate and 1.OmM CaCl, pH 5.5. SEPHADEX is a trademarkfor gel separation media owned by Pharmacia, Piscataway, NJ . The desalted material was applied to a Pharmacia FPLC MonoΞ HR 10/10 column equilibrated with the same buffer. Protease 3733 was eluded from the column using a 90 ml linear 0 - 0.2M NaCl gradient in the above buffer.
Tne resulting preparation of protease 3733 was shown to be homogeneous via SDS-PAGE, IEF, and N-terminal sequencing. Purified protease is stored at 4° C as a 1.0 mg/ l solution in column elution buffer with 50% propylene glycol.
Protein concentration was determined using the Bio-Rad protein assay kit (Bio-Rad, Rockville Centre, NY).
Biochemical Properties of Protease 3733. Figs. 1a - e shows several biochemical properties of protease 3733. Unless indicated, all data were determined under the following conditions. All studies were done with protease 3733 prepared as above and stored as indicated. Enzymatic acitvity was determined using azocasein (Sigma Chemical Co., St. Louis, MO) as the substrate. 0.5% azocasein was prepared in 0.05M tris (hydroxymethyl) aminomethane (Tris) buffer (Sigma Chemical Co., St. Louis, MO) plus 1.OmM CaCl adjusted to pH 8.0 with HCl. 100ul of an appropriate enzyme dilution was added to 900ul of 0.5% azocasein and incubated at 30° C for 10 minutes. The reaction was stopped by the addition of 300ul of 10% trichloroacetic acid. The reaction mixture was centrifuged at 12,000 rpm for 2 minutes in an Eppendorf microfuge. 800ul of supernatant fluid was withdrawn into a fresh tube containing 300ul of 0.5 N NaOH. The mixture was vortexed and the absorbanc read at 420nm. One unit of activity is the amount of enzyme required to give an absorbance change of 1.0 in 1 minute.
In Figs. 1a - e, the Activity axis represents the % relativ activity calculated by comparison of each point to the highest value, which is given a relative activity of 100.
Fig. 1a shows the effect on the activity of protease 3733 on azocasein found by varying the pH values from 4 - 12. The data in Fig. 1a indicate that protease 3733 activity against azocasein had a pH optimum of at least pH 11.
Fig. 1b shows the effect of pH on stability of protease 3733. The enzyme, at a concentration of 1mg/ml, was incubated at pH values from 4 - 12 at 4° C, dashed line; or at 23° C, solid line, for 20 hrs. and the activity was determined. The data in Fig. 1b. indicate that protease 3733 was stable for 20 hrs. at pH 5 - 9 at 4° C and stable for 20 hrs. at pH 7 - 9 at 23° C.
Fig. 1c shows the effect of temperature on activity of protease 3733. Enzymatic activity was determined at 10° - 70° C. The data in Fig. 1c indicate a temperature optimum of 50° C.
Fig. 1d shows the effect of 40° C on stability of protease 3733. The enzyme at a concentration of 1mg/ml was incubated for up to 120 min. at 40° C at a pH of 8, dashed line; or pH of 10, solid line; and the enzymatic activity determined. The data in Fig. 1d show that protease 3733 is stable at 40° C at pH 8 or pH 10.
Fig. 1e shows the effect of 50° C on stability of protease 3733. The enzyme was incubated for up to 120 min. at 50° C at a pH of 8, solid line; or pH of 10, dashed line; and the enzymatic activity determined. The data in Fig. 1d show that protease 3733 loses 50% of its activity after 15 min. at 50° C at both pH 8 and pH 10.
Figs. 2a - c show the effects of various additives on the activity of protease 3733.' Unless indicated otherwise, the conditions were the same as in Figs. 1a - e.
Fig. 2a shows the effect of (1) phenylmethylsulfonyl fluoride (PMSF) and (2) ethylenedia inetetraacetic acid (EDTA) on protease 3733 activity. The data in Fig. 2a show that PMSF at 1.0mM inhibited the activity of protease 3733 while EDTA at 5.OmM had no effect on enzyme activity.
Fig. 2b shows the effect of EDTA on the stability of protease 3733. The enzyme was incubated for up to 120 min. at pH 10 and 40° C in the presence and absence of EDTA at a concentration of 2.OmM and the activity was determined. Crosses indicated presence of EDTA points and triangles indicated control points lacking EDTA. The data in Fig. 2b indicate that EDTA drastically reduced the stability of protease 3733.
Fig. 2c shows the effect of divalent cations on stability of protease 3733. Chloride salts of a variety of cations were added to separate aliquots of enzyme solution which were held at pH 10 and 50° C for up to 120 min. At intervals indicated, samples were taken from each aliquot and the enzyme activity determined. All experimental salts were at a final concentration of 5.OmM. The experimental points on Fig. 2c are as follows: triangle, control; cross, Ba ; open square, Ca ; closed square,
Co+ ; cross in square, Mn ; cross with hyphen, Zn ; and
++ -+ diamond, Mg . The data in Fig. 2c indicat that Ca and, to a lesser extent, Mg increased thermostability. The data in
Figs. 2a - c are typical for Bacillus alkaline proteases.
The specific activity of protease 3733 was examined on several substrates including azocasein, N-succinyl-ala-ala-pro- phe p-nitroanilide (AAPF-pna), N-succinyl-ala-ala-ala p-nitroanilide (AAA-pna) , and elastin congo red, all obtained from Sigma Chemical Co., St. Louis, MO. Specific activities were compared to those obtained with subtilisin Carlsberg and subtilisin aprE.
Enzyme assays with AAPF-pna and AAA-pna as substrates were performed as follows. 1 0mM AAPF-pna or AAA-pna was prepared in dimethylsulfoxide. Reaction mixtures contained 980ul of 50mM Tris-HCl (pH 8.0) + 1.0mM CaCl, 1 Oul of either AAPF-pna or AAA-pna, and 1Oul of an appropriate enzyme dilution. The increase in absorbance at 410nm, due to the release of p-nitroaniline, was followed continuously at 25°C. One unit of activity is the amount of enzyme required to give an absorbance change of 1.0 in 1 minute.
Enzyme assays with elastin congo red were performed as follows. 1 O g of elastin congo red (Sigma Chemical Co., St. Louis, MO) was weighed into 13x100mm test tubes. 900ul of 50mM Tris-HCl (pH 8.0) + 1.0mM CaCl was added followed by the addition of 100ul of an appropriate enzyme dilution. tubes were capped and incubated for 30 minutes at 37° C with shaking. the reaction was stopped by the addition of 1.0 ml of 0.7M KPO. (pH 5.5), the tubes centrifuged at 3000 rpm for 10 minutes, and the absorbance of the supernatant fluid read at 495nm. One unit of activity is the amount of enzyme required to give an absorbance change of 1.0 in 1 minute.
Table 2 gives the specific activities of protease 3733 on the indicated substrates in comparison to those of subtilisin Carlsberg and subtilisin aprE. Specific activities are expressed as Units/mg of enzyme. The data in Table 2 indicate that the specific activity of protease 3733 on several of the substrates examined is significantly different from that of subtilisin Carlsberg and from that of subtilisin aprE. The specific activity of protease 3733 is similar to that of the subtilisins on azocasein. However, the specific activity of protease 3733 is higher than that of subtilisin aprE, and much lower than that of subtilisin Carlsberg on AAPF-pna. The specific activity of protease 3733 is much higher than that of either subtilisin on AAA-pna. The specific activity of protease 3733 is much higher than that of either subtilisin on Elastin congo red. This indicates that protease 3733 is a different and distinct enzyme from either subtilisin Carlsberg or subtilisin aprE.
Composition of Protease 3733. The amino acid compositions of protease 3733, subtilisin Carlsberg, and elastase Ya-B are compared in Table 3. Elastase Ya-B is an alkaline elastase isolated from Bacillus sp. Ya-B as described in Biochim Biophys Acta, 1986, 833, pages 439-447. The enzymes were hydrolyzed and the resultant component amino acids analyzed. Table 3 shows the number of amino acid residues which resulted from the hydrolysis of each enzyme. The amino acid compositions of protease 3744, subtilisin Carlsberg, and elastase Ya-B differ significantly from each other and indicate that these are different enzymes.
The N-terminal sequences of protease 3733, subtilisin Carlsberg, and elastase Ya-B were determined and are shown in the section "Sequence Listing" as SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3, respectively. Table 4 shows the N-terminal sequence of these enzymes. Stars in Table 4 indicate amino acids homologous to protease 3733. Protease 3733 exhibits 50% homology with subtilisin Carlsberg and 34% homology with elastase Ya-B in the N-terminal sequence of these enzymes. This indicates that the three enzymes are distinctly different proteins.
Properties of Protease 3733 and Other Proteases. Table 5 compares several biochemical properties of pronase 3733 with those of subtilisin Carlsberg and elastase Ya-B. Unless indicated, these properties were determined as in Fig 1a - e. Data for elastase Ya-B were obtained from the above publication.
The data in Table 5 indicate that the pH optima were similar for each enzyme and all were serine proteases. Protease 3733 had a much lower pi than elastase Ya-B and subtilisin Carlsberg and protease 3733 had a lower pi than serine proteases in general. Protease 3733 exhibited some degree of cross-reactivity with subtilisin Carlsberg antibodies whereas elastase Ya-B had none. The ratio of elaεtin/casein degrading activity was highest for elastase Ya-B, with the ratio for protease 3733 approximately nine times that of the ratio for subtilisin Carlsberg. In addition, an elastase from Bacillus subtilis was found to have a pH optimum of 9.0 and a molecular weight of 25,000. B. subtilis elastase is an elastase isolated from B. subtilis as described in Canadian Journal of Microbiology, 1988, 34, p. 855-859.
Hydrolysis of Denatured Lysozyme. Lysozyme hydrolysis assays were performed as follows. A 1.0 mg/ l solution of chicken eggwhite lysozyme (Sigma Chemical Co., St. Louis, MO) was prepared in 5OmM sodium borate (pH 8.0) and 1.0 ml of this solution was aliquoted into 13x100mm test tubes. The tubes were capped and placed in a boiling water bath for 5 minutes resulting in denaturation of the lysozyme. After allowing the tubes to cool, 100 ul of an appropriate enzyme dilution was added and the reaction mixture was incubated at 37° C for 30 minutes. The reaction was stopped by the addition of 300 ul of 10% trichloroacetic acid followed by centrifugation at 3000 rpm for 10 minutes. The absorbance of soluble amino acids in the supernatant fluid was read at 380nm. Assays using human milk lysozyme (Sigma Chemical Co., St. Louis, MO) were performed using this same protocol. Any changes in incubation temperature or incubation time are indicated where appropriate.
Fig. 3 illustrates the enzymatic activity of protease 3733, subtilisin Carlsberg, subtilisin aprE, and subtilisin BPN'on denatured eggwhite lysozyme. Activity was determined by incubating 25ug of purified enzyme with denatured eggwhite lysozyme under the conditions described above. The data show protease 3733 to be 5 - 6 fold more active at- hydrolyzing denatured eggwhite lysozyme than the other proteolytic enzymes.
Fig. 4 shows the effect of beta-mercaptoethanol (BME) on enzymatic activity of protease 3733 and subtilisin Carlsberg on denatured eggwhite lysozyme. The data show a two-fold enhancement of lysozyme hydrolysis by the addition of 0.4% BME for both protease 3733 and subtilisin Carlsberg. This presumably was due to the reduction of disulfide bonds in lysozyme making the protein more susceptible to proteolysis. Protease 3733 was clearly superior to subtilisin Carlsberg in that protease 3733 without addition of BME was 2.5 fold more active than subtilisin Carlsberg even when the activity of subtilisin Carlsberg was enhanced by addition of BME.
Fig. 5 shows the activity of protease 3733 and subtilisin Carlsberg on denatured human milk lysozyme with and without the addition of 0.4% BME. Without the addition of BME, protease 3733 exhibited a 4 - 5 fold higher activity on human milk lysozyme than did subtilisin Carlsberg. As in the case of chicken eggwhite lysozyme as substrate, the addition of BME resulted in a two-fold enhancement of enzymatic activity for both enzymes. However, protease 3733 without addition of BME was 1.5 - 2 fold more active on denatured human milk lysozyme than was subtilisin Carlsberg enhanced with BME. Protease 3733 Treatment of Contact Lenses. Protein-contaminated contact lenses may be cleaned by incubation in a cleansing preparation containing protease 3733. A suitable preparation is a sterile aqueous solution of 0.05 M sodium borate buffer pH 8.0 with protease 3733 at 1 mg/ml. Contaminated contact lens are immersed in the preparation and held at room temperature for 30 min. The lenses are rinsed well with sterile physiological saline before use. Protein contamination is effectively removed from contact lenses using this preparation and method.
In an optional formulation for cleaning contaminated contact lenses, 0.4% BME may be included in preparation.
Suitable cleansing preparations also may be formulated in nonaqueous solvents, such as hexane, cyclohexane, ethanol, methanol, and dimethylsulfoxide. Such solutions may be buffered to insure a high level of enzymatic activity. The method of use is as for agueous solutions.
The invention has been described in detail with particular reference to preferred embodiments thereof: however, it should be understood that variations and modifications can be made within the spirit and scope of the invention and the same should not be limited except as set forth in the appended claims.
TABLE 1
Mobility
Oxidase
Catalase
Spore Production Observed
Acid Produced From:
Anaerobic Dextrose
Aerobic Dextrose
Maltose
Trehalose
Sucrose
Xylose
Lactose
Arabinose
Mannitol
Cellobiose
Adonitol
Inositol
Raffinose
Rhamnose
Sorbitol
Mannose
Galactose
Phenylalanine Deaminase Ornithine Decarboxylase
Lysine Decarboxylase
Arginine Decarboxylase
Beta Galactosidase
Nitrate Reduction
Denitrification
Voges-Proskauer
Citrate (as sole carbon source)
Urease
Hydrogen Sulfide
Indol
Eεculin Hydrolysis
Starch Hydrolysis
Casein Hydrolysis +
Elastin Hydrolysis +
TABLE 2
Substrate Protease 3733 Subtilisin Subtilisin
Carlsberg aprA
Azocasein 14.4 16.7 16.2
AAPF-pna 393 4286 370
AAA-pna 22.8 10.0 1.8
Elastin congo red 2.6 0.4 0.2
18
Table 3
Amino Acid Protease 3744
ASX 35
Glx 18 Ser 22
Gly 40
His 9
Arg 10
Thr 13
Ala 36
Pro 13
Tyr 13
Val 23
Met 8
Cys 0
He 13
Leu 19
Phe 7
Lys 4
Trp 1
Total 284 273 239 Gly Ala
25 Asn Val Lys Val Ala
TABLE 5
Property Protease Elastase Subtilisin 3733 Ya-B Carlsberg
10.0
60
28,000 9.4
Ala
++
0.02
SEQUENCE LISTING
(1 ) GENERAL INFORMATIO :
(i) APPLICANT: Fiske, Michael J.
Middlebrook, Susan M.
Steele, D. Bernie Barnitz, Joy T.
(ii) TITLE OF INVENTION: Alkaline Protease 3733, Its
Production and Use In Cleaning Contact Lens
(iii) NUMBER OF SEQUENCES: 3
(iv) CORRESPONDENCE ADDRESS:
(A) Addressee: Genencor International Inc.
(B) Street: 180 Kimball Way
(C) City: South San Francisco
(D) State: California
(E) Country: USA
(F) ZIP: 94080
(v) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Disc
(B) COMPUTER: 1MB PS/2
(C) OPERATING SYSTEM: DOS (D) SOFTWARE: Multimate
(viii) ATTORNEY/AGENT INFORMATION
(A) NAME: Passe, James G.
(B) REGISTRATION NUMBER: 29,966
(ix) TELECOMMUNICATION INFORMATION:
(A) TELEPHONE: (415)742-7500
(B) TELEFAX: (415)583-8269
(2) INFORMATION FOR SEQ ID NO:1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 amino acid residues
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(iii) HYPOTHETICAL: no
(iv) ANTI-SENSE: no
(v) FRAGMENT TYPE: -N-terminal fragment (vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus sp.
(B) INDIVIDUAL/ISOLATE: IAM 011105, ATCC 55142
(C) CELL TYPE: unicellular bacterium
(D) DEVELOPMENTAL STAGE: vegetative cells
(vii) IMMEDIATE SOURCE: bacteria isolated, cultured; enzyme isolated, sequenced
(ix) FEATURE
(A) NAME/KEY: N-terminal sequence of alkaline protease, protease 3733
(C) IDENTIFICATION METHOD: Biochemical assay
(D) OTHER INFORMATION: active as alkaline protease especially active on denatured lysozyme and elastin, useful for cleaning contact lens
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:
Gin Thr Val Pro Trp Gly He Pro Tyr He Tyr Ser Asp Val Val 1 5 10 15
Xaa Xaa Gin Gly Tyr Phe Gly Asn Gly Val Lys Val Ala
20 25
(3) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 amino acid residues
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(iii) HYPOTHETICAL: no
(iv) ANTI-SENSE: no
(v) FRAGMENT TYPE: -N-terminal fragment
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus subtilis
(B) INDIVIDUAL/ISOLATE: Var. Carlsberg
(C) CELL TYPE: unicellular organism
(vii) IMMEDIATE SOURCE: enzyme obtained commercially, sequenced
(ix) FEATURE
(A) NAME/KEY: N-terminal sequence of alkaline protease, subtilisin Carlsberg
(C) IDENTIFICATION METHOD: Biochemical assay (D) OTHER INFORMATION: active as alkaline protease
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:
Ala Gin Thr Val Pro Tyr Gly He Pro Leu He Lys Ala Asp Lys 1- 5 10 15
Val Gin Ala Gin Gly Phe Lys Gly Ala Asn Val Lys Val Ala
20 25
(4) INFORMATION FOR SEQ ID NO:3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 amino acid residues
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(iii) HYPOTHETICAL: no
(iv) ANTI-SENSE: no
(v) FRAGMENT TYPE: -N-terminal fragment (vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus sp.
(B) INDIVIDUAL/ISOLATE: Ya-B
(D) DEVELOPMENTAL STAGE: vegetative cells (G) CELL TYPE: unicellular bacterium
(vii) IMMEDIATE SOURCE: enzyme isolated from culture, sequenced
(ix) FEATURE
(A) NAME/KEY: N-terminal sequence of alkaline protease, elastase Ya-B
(C) IDENTIFICATION METHOD: biochemical assay
(D) OTHER INFORMATION: active as alkaline protease
(x) PUBLICATION INFORMATION
(C) JOURNAL: Biochim Biophys Acta
(D) VOLUME: 833
(F) PAGES: 439-447
(G) DATE: 1986
( xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 3 :
Gly Xaa Xaa Pro Trp Gly He Asn Arg Val Gin Ala Pro He Ala 1 5 1 0 1 5
Gin Ser Arg Gly Phe Ala Gly Ala Gly Val Arg Val Ala
20 25 28
CLAIMS We claim:
1. A Bacillus sp. alkaline protease "protease 3733" enzy characterized by activity in hydrolyzing denatured lysozyme, as a serine protease, with a molecular weight of about 27,000 daltons based on SDS- PAGE analysis, an amino acid composition as set out in Table 3, a N-terminal sequence as set out in SEQ ID NO:1, a pH optimum of at least pH 11.0 with azocasein, a temperature optimum of about 50° C, a pi of about 4.9, and an activity ratio on elastin/casein of about 0.18.
2. A culture of the microorganism Bacillus sp. strain
IAM 011105 , said culture being capable of producing the alkali protease enzyme "protease 3733" in a recoverable quantity upon fermentation in an aqueous nutrient medium containing assimilab sources of carbon, nitrogen, and inorganic substances.
3. A biologically pure culture of the microorganism Bacillus sp. strain IAM 011105, said culture being capable of producing the alkaline protease enzyme "protease 3733" in a recoverable quantity upon fermentation in an aqueous nutrient medium containing assimilable sources of carbon, nitrogen, and inorganic substances.
4. A process for producing a novel alkaline protease

Claims

"protease 3733", as recited in claim 1, which comprises the steps: culturing a protease 3733-producing bacterium belonging to the genus of Bacillus in a culture medium, and collecting protease 3733 from the culture medium.
5. A process according to claim 4, wherein the protease 3733-producing bacterium is Bacillus sp. IAM 011105 strain.
6. A process according to claim 4, wherein the culture medium is tryptic soy broth buffered with CAPS buffer at pH 9.0.
7. A process according to claim 4, wherein culturing is conducted aerobically at about 30° C.
8. A process for cleaning protein contaminated contact lenses comprising the step: soaking the contact lenses in a solution of alkaline protease 3733.
9. The process of claim 8 wherein the solution of alkaline protease 3733 is an aqueous solution.
10. A cleansing preparation for contact lens comprising alkaline protease 3733 in a buffered solution at an alkaline pH.
11. The cleansing preparation of claim 10 wherein the pH is about 7.0 to about 13.0
12. The cleansing preparation of claim 10 wherein the buffer is sodium borate.
13. The cleansing preparation of claim 10 wherein the pH i s about 8 . 0 .
14. The cleansing preparation of claim 10 further comprising beta-mercaptoethanol at a concentration adequate to enhance the activity of the alkaline protease 3733.
15. The cleansing preparation of claim 14 wherein the beta-mercaptoethanol is at a concentration of about 0.4%.
16. The cleansing preparation of claim 10 wherein the solution of alkaline "protease 3733 is a nonaqueous solvent.
17. The cleansing preparation of claim 16 wherein the nonaqueous solvent is chosen from the group consisting of hexane, cyclohexane, ethanol, methanol, and dimethylsulfoxide.
EP19920910656 1991-03-29 1992-03-30 Alkaline protease 3733, its production and use in cleaning contact lens. Withdrawn EP0578767A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67772691A 1991-03-29 1991-03-29
US677726 1991-03-29
PCT/US1992/002597 WO1992017579A1 (en) 1991-03-29 1992-03-30 Alkaline protease 3733, its production and use in cleaning contact lens

Publications (2)

Publication Number Publication Date
EP0578767A1 EP0578767A1 (en) 1994-01-19
EP0578767A4 true EP0578767A4 (en) 1994-12-07

Family

ID=24719881

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920910656 Withdrawn EP0578767A4 (en) 1991-03-29 1992-03-30 Alkaline protease 3733, its production and use in cleaning contact lens.

Country Status (4)

Country Link
EP (1) EP0578767A4 (en)
JP (1) JPH06506597A (en)
CA (1) CA2105559A1 (en)
WO (1) WO1992017579A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405767A (en) * 1992-04-08 1995-04-11 Solvay Enzymes, Inc. Purified enzyme concentrate and method of preparation
ES2174853T3 (en) * 1992-09-24 2002-11-16 Genencor Int CLEANING COMPOSITIONS CONTAINING NEW ALKALINE PROTEASES.
US5718895A (en) * 1995-11-16 1998-02-17 Alcon Laboratories, Inc. Enzymes with low isoelectric points for use in contact lens cleaning
DK1971216T4 (en) 2005-12-29 2019-07-22 Wrigley W M Jun Co CHEWING GUM CONTAINING STYRENE-DIEN BLOCK COPYLYMERS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0257821A1 (en) * 1986-07-31 1988-03-02 Genencor, Inc. Contact lens cleaning solution
WO1990004022A1 (en) * 1988-10-11 1990-04-19 Basf Aktiengesellschaft Proteolytic alkaline enzyme, production and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838009A (en) * 1968-10-25 1974-09-24 Kyowa Hakko Kogyo Kk Process for producing detergent resisting alkaline protease
US4052262A (en) * 1969-05-31 1977-10-04 Rikagaku Kenkyusho Preparation of an alkaline protease
JPS5039151B2 (en) * 1972-09-02 1975-12-15
GB1519148A (en) * 1974-11-19 1978-07-26 Gist Brocades Nv Compositions of matter
JPS6055118B2 (en) * 1982-02-08 1985-12-03 昭和電工株式会社 Novel bacterial alkaline protease and its production method
US4511490A (en) * 1983-06-27 1985-04-16 The Clorox Company Cooperative enzymes comprising alkaline or mixtures of alkaline and neutral proteases without stabilizers
US4670178A (en) * 1985-09-09 1987-06-02 Allergan Pharmaceuticals, Inc. Method for the simultaneous cleaning and disinfecting of contact lenses
US4771003A (en) * 1985-10-22 1988-09-13 Genex Corporation Heat stable alkaline proteases produced by a bacillus
US4764470A (en) * 1986-02-05 1988-08-16 Genex Corporation Alkaline protease produced by a bacillus
CA2009118C (en) * 1989-02-21 1996-02-27 Mary F. Mowrey-Mckee Method and composition for cleaning and disinfecting contact lenses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0257821A1 (en) * 1986-07-31 1988-03-02 Genencor, Inc. Contact lens cleaning solution
WO1990004022A1 (en) * 1988-10-11 1990-04-19 Basf Aktiengesellschaft Proteolytic alkaline enzyme, production and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9217579A1 *

Also Published As

Publication number Publication date
CA2105559A1 (en) 1992-09-30
JPH06506597A (en) 1994-07-28
EP0578767A1 (en) 1994-01-19
WO1992017579A1 (en) 1992-10-15

Similar Documents

Publication Publication Date Title
CA1193213A (en) Alkaline protease and preparation method thereof
US5275945A (en) Alkaline proteases stable in heavy-duty detergent liquids
US4797362A (en) Alkaline proteases and microorganisms producing same
EP0495401B1 (en) Novel alkaline proteinase and process for producing the same
US5518917A (en) Bacillus proteolyticus species which produce an alkaline protease
JPH05252949A (en) Alkaline protease, its production, its usage and microorganism producing the same protease
JP4137526B2 (en) Keratinase and production method thereof
WO1992017579A1 (en) Alkaline protease 3733, its production and use in cleaning contact lens
WO2006054595A1 (en) Novel high alkaline protease and use thereof
US6156557A (en) Alkaline protease from streptomyces sp. and method for preparing the same
KR0145485B1 (en) Thermoactinomyces sp.e79 and new proteolytic enzyme produced therefrom
JP4054577B2 (en) Alkaline protease producing bacteria
JPH07236482A (en) Alkaline protease, its production and microorganism producing the protease
JP2509540B2 (en) Novel microorganism that produces new protease
WO2004085639A9 (en) Novel alkaline protease
JP2985018B2 (en) New microorganism
JP3026111B2 (en) Novel alkaline protease and method for producing the same
KR0150917B1 (en) Xanthomonas maltophilia yl-37 and alkaline protease
JP4085486B2 (en) A novel lysine residue-specific enzyme-producing bacterium
JP2000060547A (en) New alkali protease and its production
JPH08322563A (en) Alkali protease having optimum low-temperature, microorganism producing the alkali protease and production of the alkali protease
JPH09224666A (en) Low temperature active protease cp58 low temperature bacterium
JPH0763366B2 (en) Novel protease
JPH08322564A (en) Protease having optimum low-temperature, microorganism producing the protease and production of the protease
JPH06121676A (en) New alkali lytic enzyme and its production

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931022

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19941020

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19951003